Stocks
H. Lundbeck A/SHLUYY
OTCHealthcareBiotechnology$22.00+0.00%
Price as of · delayed, not real-time
Specializing in central nervous system disorders, this Danish pharmaceutical firm develops and markets treatments for depression, Alzheimer's, and Parkinson's. Investors monitor its pipeline of neurological therapies and international expansion in competitive CNS markets.
Market Cap: $052W Range: $10.00-$31.15
Congressional Interest in H. Lundbeck A/S (HLUYY)
1 member of Congress has disclosed 1 trade in H. Lundbeck A/S (HLUYY), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading HLUYY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-03-18 | Greg Gianforte | buy | $1K-$15K |